Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chang

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Journal of Diabetes Science and Technology|October 6, 2024
High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic NeuropathyErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 11, 2022
High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled TrialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
Diabetes Research and Clinical Practice|August 3, 2023
Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
JAMA Neurology|April 5, 2021
Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical TrialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
The FEBS Journal|July 29, 2021
ADP-ribosyltransferases, an update on function and nomenclatureBernhard Lüscher, Ivan Ahel, Matthias Altmeyer, et al.
Cancer Discovery|October 6, 2017
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal AdenocarcinomaEirini Pectasides, Matthew D Stachler, Sarah Derks, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Journal of Diabetes Science and Technology|October 6, 2024
High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic NeuropathyErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2024
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024Thomas W Flaig, Philippe E Spiess, Michael Abern, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|July 11, 2022
High-Frequency 10-kHz Spinal Cord Stimulation Improves Health-Related Quality of Life in Patients With Refractory Painful Diabetic Neuropathy: 12-Month Results From a Randomized Controlled TrialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
Diabetes Research and Clinical Practice|August 3, 2023
Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
JAMA Neurology|April 5, 2021
Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy: A Randomized Clinical TrialErika A Petersen, Thomas G Stauss, James A Scowcroft, et al.
The FEBS Journal|July 29, 2021
ADP-ribosyltransferases, an update on function and nomenclatureBernhard Lüscher, Ivan Ahel, Matthias Altmeyer, et al.
Cancer Discovery|October 6, 2017
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal AdenocarcinomaEirini Pectasides, Matthew D Stachler, Sarah Derks, et al.
Pageof 14